New study tests better pain relief for broken ribs
NCT ID NCT06519929
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study compares three pain relief methods for people with three or more broken ribs on one side. Participants will receive either a nerve block with a numbing medicine, a lidocaine infusion, or standard pain care. The goal is to see which approach reduces opioid use and improves breathing over the first three days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ropivacaine (nerve block) and lidocaine (infusion)
What this could lead to
If successful, this study could point toward better pain management for rib fractures, reducing opioid use and improving recovery.
What could go wrong
This is a very small pilot study with only 24 participants, so results may not apply broadly. The interventions carry risks like allergic reactions or nerve damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RIB FRACTURES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States